Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs

Table 1 Characteristics of UFO study participants participating in the Rapid HCV testing study: (1) overall; and (2) in association with having chosen the rapid HCV test

Characteristic	Overall (N = 129)	Rapid test (N = 107)	Standard blood draw (N = 22)	P-value¹
	N	N (%)	N (%)
Median age (range, IQR)[yrs]	25 (23–27)	25 (23–27)	25 (23–27)	0.75
Gender
Male	88	72 (81.8)	16 (18.2)	0.80
Female	40	34 (85.0)	6 (15.0)
Ethnicity
Non-white	55	48 (87.3)	7 (12.7)	0.35
White	74	59 (79.7)	15 (20.3)
Ethnicity
Asian, Asian-American	1	1 (100)	0 (0)	0.56
African American	5	4 (80.0)	1 (20.0)
Filipino	1	1 (100)	0 (0)
Latino/Hispanic	7	6 (85.7)	1 (14.3)
Native American	5	3 (60.0)	2 (40.0)
Caucasian	74	59 (79.7)	15 (20.3)
Other	9	8 (88.9)	1 (11.1)
Mixed	27	25 (92.6)	2 (7.4)
Previously tested for HIV
Yes	105	86 (81.9)	19 (18.1)	1.00
No	21	18 (85.7)	3 (14.3)
Missing^*	3		3
Self report anti-HIV results
Negative	101	83 (82.2)	18 (17.8)	1.00
Positive	5	4 (80.0)	1 (20.0)
Homeless, last 3 months
Yes	101	82 (81.2)	19 (18.8)	0.40
No	28	25 (89.3)	3 (10.7)
Completed grade 12
Yes	93	78 (83.9)	15 (16.1)	0.79
No	36	29 (80.6)	7 (19.4)
Seen health provider, last 3 months
Yes	64	52 (81.3)	12 (18.8)	0.82
No	64	54 (84.4)	10 (15.6)
Missing^*	1		1
Obtained new needles from NEP, last 3 months
Yes	95	77 (81.1)	18 (19)	0.43
No	33	29 (87.9)	4 (12.1)
Missing^*	1		1
Median years injecting (range, IQR)[yrs]	4.2 (1.7-7.5)	4 (1.5-7.7)	4.9 (2.1-6.5)	0.51
Inject every day in past 30 days
Yes	37	29 (78.4)	8 (21.6)	0.44
No	91	77 (84.6)	14 (15.4)
Missing^*	1		1

*Missing values were not factored into the proportions or p-values presented.
¹Fisher’s Exact Test for frequency and Kruskal-Wallis Test for median value comparison.

ISSN: 1471-2458